Avicenna Day 2020

 

Tuesday 25 August 2020

Time: 14.00 – 18:30 CEST / 13.00 - 17.30 BST / 17.30 - 22.00 IST / 8.00 - 12.30 EDT / 7.00 -11.30 CDT

 

 

14:00 – 14:15

Welcome and presentation of the Avicenna Successful Journey

Thierry Marchal, Secretary General, Avicenna Alliance

14:15 – 14:40

Successful use of in silico for regulatory approval

14:15 – 14:25

Medical Device Case study – Steven Levine, Dassault Systèmes

14:25 – 14:35

Pharmaceutical case study – François Boissel, Novadiscovery

14:35 – 14:40

Q&A with the audience moderated by Alicia Waterkeyn (Avicenna Secretariat, RPP group)

14:40 – 15:55

Session I - A policy community

14:40 – 14:55

Mission, achievements and plan

Emmanuelle Voisin, Policy Development Working Group Leader, Voisin Consulting Life Sciences

14:55 – 15:05

Important directions for Europe in 2021 & 2022

James Kennedy, Avicenna Secretariat, RPP Group

15:05 – 15:15

Towards Good Simulation Practice

Luca Emili, Chair of the GSP Taskforce, InsilicoTrials Technologies

15:15 – 15:30

A valuable collaboration with EMA

Liesbet Geris Research and Technology Working Group Leader, VPHi, University of Liège & KU Leuven

Flora Musuamba, European Medicines Agency, Modelling and Simulation Working Party

15:30 – 15:45

Engaging with Notified Bodies

Simon Sonntag, Chair of the Notified Bodies Taskforce, Virtonomy

Françoise Schlemmer, Director, The European Association for Medical devices of Notified Bodies (Team-NB))

15:45 – 15:55

Q&A with the audience moderated by Alicia Waterkeyn, RPP group

15:55 – 16:25

Session II - An international community

15:55 – 16:00

Mission, achievements and plan

Markus Reiterer, International Working Group Leader, Medtronic

16:00 – 16:10

Computer modelling as regulatory evidence at FDA

Brent Craven, U.S. Food and Drug Administration

16:10 – 16:20

Global Recommendations for in silico Evidence

Marc Horner, Ansys

16:20 – 16:25

Q&A with the audience moderated by Alicia Waterkeyn, RPP group

16:25 – 16:40

Break

16:40 – 17:45

Session III - A research & technology community

16:40 – 16:50

Mission, achievements and plan

Liesbet Geris, Research and Technology Working Group Leader, VPHi, University of Liège & KU Leuven

16:50 – 17:05

Certified Materials Library

Venkat Perumal, Chair of the Materials Library Taskforce, Stryker

Nele Famaey, KU Leuven

17:05 – 17:20

Funding for in silico in Horizon Europe projects

Liesbet Geris, VPHi, KU Leuven, ULiege

Nathalie Virag, Medtronic

17:20 – 17:35

The role of AI for in silico medicine

Jérôme Noailly, VPHi, Pompeu Fabra University, Barcelona

Payman Afshari, DePuy Spine, Johnson and Johnson

17:35 – 17:45

Q&A with the audience moderated by Alicia Waterkeyn, RPP group

17:45 – 18:20

Session IV – Interactive Panel Discussion with Avicenna Alliance Board Members

Liesbet Geris, Research and Technology Working Group Leader, VPHi, University of Liège & KU Leuven

Emmanuelle Voisin, Policy Development Working Group Leader, Voisin Consulting Life Science

Markus Reiterer, International Working Group Leader, Medtronic

Luca Emili, Avicenna Treasurer, InsilicoTrials Technologies

James Kennedy, Avicenna Secretariat, RPP Group

Thierry Marchal, Secretary General, Avicenna Alliance

18:20 – 18:30

Concluding Remarks

Thierry Marchal, Secretary General, Avicenna Alliance

Avicenna Alliance news

Our new position paper on in silico evidence in the regulatory approval of medical devices is out!

The Avicenna Alliance is proud to announce the recent publication of its new position paper...

find out more ›

Happy 5th Anniversary to the Avicenna Alliance!  

5 years ago, based on the very enlightening Avicenna Roadmap Project Report, the Avicenna Alliance was established at the suggestion of European...

find out more ›

EU New Medical Device Regulation now in force! In silico mentioned for the first time

After a one-year postponement following the COVID-19 pandemic, the European Commission’s Medical Devices...

find out more ›

The European Commission adopts Communication on Europe's global approach to cooperation in research and innovation

On 18 May, the European Commission adopted a Communication on its global approach...

find out more ›

Avicenna Alliance provides feedback on the European Commissions’ roadmap for the revision of the EU general pharmaceuticals legislation

On 27 April, the Avicenna Alliance has submitted its feedback...

find out more ›

Show all activites

Sign up for our monthly newsletter!


Sign up